We are live on ! Find out more
KRYS icon

Krystal Biotech
KRYS

110 hedge funds and large institutions have $589M invested in Krystal Biotech in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 47 increasing their positions, 22 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 10

114% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 22

22% more funds holding

Funds holding: 90 → 110 (+20)

17% more capital invested

Capital invested by funds: $502M → $589M (+$87.4M)

5.51% more ownership

Funds ownership: 66.66% → 72.17% (+5.5%)

7% less call options, than puts

Call options by funds: $1.03M | Put options by funds: $1.11M

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
110
Holders Change
+20
Holders Change %
+22.22%
% of All Funds
2.26%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
30
Increased
47
Reduced
22
Closed
10
Calls
$1.03M
Puts
$1.11M
Net Calls
-$72K
Net Calls Change
-$72K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$25.9M
2
FLAM
First Light Asset Management
Minnesota
+$22.3M
3
RG
Redmile Group
California
+$17.2M
4
BlackRock
BlackRock
New York
+$13.6M
5
HRCM
Hood River Capital Management
Florida
+$13.6M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$28.3M
2
Citadel Advisors
Citadel Advisors
Florida
-$25M
3
BBA
Baker Bros. Advisors
New York
-$6.2M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$3.6M
5
EI
EAM Investors
California
-$3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Handelsbanken Fonder
26
Handelsbanken Fonder
Sweden
$3.73M +$4.33M +90,000 New
Charles Schwab
27
Charles Schwab
California
$3.17M +$368K +7,645 +11%
SST
28
S Squared Technology
New York
$2.91M +$481K +10,000 +17%
JP Morgan Chase
29
JP Morgan Chase
New York
$2.8M +$1.01M +20,954 +45%
Verition Fund Management
30
Verition Fund Management
Connecticut
$2.75M -$938K -19,504 -23%
Renaissance Technologies
31
Renaissance Technologies
New York
$2.54M +$2.67M +55,400 +923%
Fidelity International
32
Fidelity International
Bermuda
$2.52M +$2.93M +60,900 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$2.44M -$303K -6,307 -10%
MAM
34
Martingale Asset Management
Massachusetts
$2.38M +$1.57M +32,605 +131%
Aviva
35
Aviva
United Kingdom
$2.29M -$1.81M -37,644 -41%
William Blair & Company
36
William Blair & Company
Illinois
$2.07M -$528K -10,982 -18%
JGC
37
J. Goldman & Co
New York
$1.87M +$2.17M +45,202 New
N
38
Nuveen
North Carolina
$1.83M +$121K +2,524 +6%
Neuberger Berman Group
39
Neuberger Berman Group
New York
$1.78M +$866K +18,000 +72%
GECH
40
Garnet Equity Capital Holdings
New York
$1.66M +$1.92M +40,000 New
NIP
41
Nicholas Investment Partners
California
$1.64M -$2.04M -42,408 -52%
Dimensional Fund Advisors
42
Dimensional Fund Advisors
Texas
$1.49M +$1.73M +35,858 New
Hudson Bay Capital Management
43
Hudson Bay Capital Management
Connecticut
$1.45M +$1.68M +35,000 New
Citigroup
44
Citigroup
New York
$1.42M -$1.23M -25,488 -43%
Bessemer Group
45
Bessemer Group
New Jersey
$1.22M +$842K +17,500 +146%
AI
46
Atom Investors
Texas
$1.21M -$918K -19,084 -40%
Ameriprise
47
Ameriprise
Minnesota
$1.19M +$625K +12,996 +82%
Swiss National Bank
48
Swiss National Bank
Switzerland
$1.18M +$318K +6,600 +30%
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$1.13M +$182K +3,789 +16%
BBHC
50
Brown Brothers Harriman & Co
New York
$1.12M +$1.3M +27,000 New
1
2
3 4 5

KRYS Hedge Fund Activity: Q2 2020 in Review

110 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Krystal Biotech (KRYS) for Q2 2020, worth a combined $589M — up 17% from $502M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new KRYS positions and 10 closed out — a net gain of 20 holders — while 47 added to existing stakes and 22 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $25.9M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $28.3M sold.

  • 110 institutional investors held Krystal Biotech (KRYS) as of Q2 2020, up from 90 in Q1 2020.
  • Funds reported $589M of Krystal Biotech stock for Q2 2020, up 17% quarter-over-quarter.
  • 30 funds opened new Krystal Biotech positions in Q2 2020 and 10 closed out, a net change of +20 holders.
  • The largest Krystal Biotech buyer in Q2 2020 was Point72 Asset Management, an estimated $25.9M added.
  • The largest Krystal Biotech seller in Q2 2020 was Consonance Capital Management, an estimated $28.3M sold.

Based on aggregated 13F filings for Q2 2020.